Management of Secondary Poor Response to Botulinum Toxin in Cervical Dystonia: A Multicenter Audit.

Our audit shows that optimizing BoNT dose or injection strategy largely led to improvements in those with suboptimal response and in those reporting no response without resistance. It would be helpful to standardize investigations of potential resistance in those with no therapeutic response.